| Tretinoin | Approved Investigational Nutraceutical | ITPKA | 3706 |
upregulated | Tretinoin results in increased expression of ITPKA mRNA | 15q15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITPR1 | 3708 |
downregulated | Tretinoin results in decreased expression of ITPR1 mRNA | 3p26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ITPR2 | 3709 |
upregulated | Tretinoin results in increased expression of ITPR2 mRNA | 12p11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | ITPR3 | 3710 |
downregulated | Tretinoin results in decreased expression of ITPR3 mRNA | 6p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ITPRIPL2 | 162073 |
upregulated | Tretinoin results in increased expression of ITPRIPL2 mRNA | 16p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IVL | 3713 |
downregulated | Tretinoin analog results in decreased expression of IVL mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IVL | 3713 |
downregulated | Tretinoin results in decreased expression of IVL mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IVL | 3713 |
upregulated | Tretinoin results in increased expression of IVL mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IVNS1ABP | 10625 |
upregulated | Tretinoin results in increased expression of IVNS1ABP mRNA | 1q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | JADE1 | 79960 |
downregulated | Tretinoin results in decreased expression of JADE1 mRNA | 4q28.2 | |
| Tretinoin | Approved Investigational Nutraceutical | JADE2 | 23338 |
upregulated | Tretinoin results in increased expression of JADE2 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | JAG1 | 182 |
downregulated | Tretinoin results in decreased expression of JAG1 mRNA | 20p12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | JAK1 | 3716 |
downregulated | Tretinoin results in decreased expression of JAK1 mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | JAK1 | 3716 |
upregulated | Tretinoin results in increased expression of JAK1 mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | JARID2 | 3720 |
downregulated | Tretinoin results in decreased expression of JARID2 mRNA | 6p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | JMJD4 | 65094 |
downregulated | Tretinoin results in decreased expression of JMJD4 mRNA | 1q42.13 | |
| Tretinoin | Approved Investigational Nutraceutical | JPH1 | 56704 |
downregulated | Tretinoin results in decreased expression of JPH1 mRNA | 8q21.11 | |
| Tretinoin | Approved Investigational Nutraceutical | JPH3 | 57338 |
downregulated | Tretinoin results in decreased expression of JPH3 mRNA | 16q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | JPH4 | 84502 |
downregulated | Tretinoin results in decreased expression of JPH4 mRNA | 14q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | JSRP1 | 126306 |
downregulated | Tretinoin results in decreased expression of JSRP1 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | JUND | 3727 |
upregulated | Tretinoin results in increased expression of JUND mRNA | 19p13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | KANK4 | 163782 |
upregulated | Tretinoin results in increased expression of KANK4 mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KANSL3 | 55683 |
upregulated | Tretinoin results in increased expression of KANSL3 mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KAT5 | 10524 |
upregulated | Tretinoin results in increased expression of KAT5 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KAT6B | 23522 |
upregulated | Tretinoin results in increased expression of KAT6B mRNA | 10q22.2 | |